Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer

Androgen deprivation therapy (ADT) is a widely used treatment for patients with hormone-sensitive prostate cancer (PCa). However, duration of treatment response varies, and most patients eventually experience disease progression despite treatment. Leuprorelin is a luteinizing hormone-releasing hormo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yixuan, Tang, Fei, Talbert, Jeffery C., Ng, Chee M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092991/
https://www.ncbi.nlm.nih.gov/pubmed/32208461
http://dx.doi.org/10.1371/journal.pone.0230571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092991/
https://www.ncbi.nlm.nih.gov/pubmed/32208461
http://dx.doi.org/10.1371/journal.pone.0230571

Ejemplares similares